Bank of America (NASDAQ: MGNX) reports 5.1% ownership in MacroGenics

Rhea-AI Filing Summary

Bank of America Corp reported beneficial ownership of 3,258,574 shares of MacroGenics, Inc. common stock, equal to 5.1% of the class. The filing bases its calculation on 63,560,068 outstanding shares as of March 27, 2026.

The statement is a Schedule 13G filed on behalf of Bank of America and certain subsidiaries, listing shared voting and dispositive power over the reported shares. The filing is signed by an authorized signatory on May 14, 2026.

Insights

Institutional Ownership Analyst

Bank of America reports a 5.1% passive stake in MacroGenics.

The filing shows 3,258,574 shares beneficially owned with shared voting and dispositive power. The calculation cites March 27, 2026 share totals of 63,560,068, which produces the 5.1% figure.

Because this is a Schedule 13G, the position is presented as passive under the reported classification. Subsequent filings or amendments would disclose any change in voting intent or a shift to active ownership.

Key Figures

Shares beneficially owned: 3,258,574 shares Percent of class: 5.1% Shares outstanding (basis): 63,560,068 shares

3 metrics

Shares beneficially owned 3,258,574 shares reported on Schedule 13G

Percent of class 5.1% calculated using outstanding shares as of March 27, 2026

Shares outstanding (basis) 63,560,068 shares as disclosed in issuer DEF 14A, share totals as of March 27, 2026

Key Terms

Schedule 13G, beneficial ownership, shared dispositive power

3 terms

Schedule 13G regulatory

"The filing is a Schedule 13G filed on behalf of Bank of America"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

beneficial ownership financial

"Amount beneficially owned: 3,258,574.00 (b) Percent of class: 5.1%"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

shared dispositive power regulatory

"Shared power to dispose or to direct the disposition of: 3,258,574.00"

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

MACROGENICS INC

(Name of Issuer)

Common Stock

(Title of Class of Securities)

556099109

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 556099109

1

Names of Reporting Persons

BANK OF AMERICA CORP /DE/

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 3,258,574.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 3,258,574.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,258,574.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.1 %

12

Type of Reporting Person (See Instructions)

HC

Comment for Type of Reporting Person: The beneficial ownership calculation relies on the 63,560,068 outstanding shares disclosed in the Form DEFA14A by the issuer on April 22, 2026, which reports share totals as of March 27, 2026.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: MACROGENICS INC
(b)	Address of issuer's principal executive offices: 9704 MEDICAL CENTER DRIVE, Rockville, MARYLAND, 20850.
Item 2.
(a)	Name of person filing: BANK OF AMERICA CORP /DE/
(b)	Address or principal business office or, if none, residence: 100 N TRYON ST CHARLOTTE, NC 28255
(c)	Citizenship: Delaware
(d)	Title of class of securities: Common Stock
(e)	CUSIP Number(s): 556099109
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 3,258,574.00
(b)	Percent of class: 5.1%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0.00
	(ii) Shared power to vote or to direct the vote: 3,258,574.00
	(iii) Sole power to dispose or to direct the disposition of: 0.00
	(iv) Shared power to dispose or to direct the disposition of: 3,258,574.00
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. This statement on Schedule 13G is being filed by Bank of America Corporation on behalf of itself and its wholly owned subsidiaries BofA Securities, Inc., a broker dealer registered under section 15 of the Act (15 U.S.C. 78o); Bank of America N.A., a bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); and Merrill Lynch International, a non-U.S. institution in accordance with section 240.13d-1(b)(1)(ii)(J).
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

BANK OF AMERICA CORP /DE/

Signature:	/s/ Monica Yako
Name/Title:	Authorized Signatory
Date:	05/14/2026

FAQ

What stake does Bank of America hold in MacroGenics (MGNX)?

Bank of America reported 3,258,574 shares, representing 5.1% of MacroGenics common stock based on 63,560,068 outstanding shares as of March 27, 2026.

Does the Schedule 13G indicate active control of MacroGenics?

No. The Schedule 13G classification in this filing indicates the position is reported as passive; the filing lists shared voting and dispositive power but does not state active control or intent.

Which Bank of America entities are included in this filing?

The filing is made by Bank of America Corporation on behalf of itself and subsidiaries including BofA Securities, Inc., Bank of America N.A., and Merrill Lynch International as stated in the filing.

What date does the ownership calculation reference?

The beneficial ownership calculation relies on share totals reported in the issuer’s DEF 14A as of March 27, 2026, which the filing cites when computing the 5.1% figure.

When was the Schedule 13G signed?

The Schedule 13G excerpt is signed by an authorized signatory on May 14, 2026, per the signature block in the filing.